Cargando…

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

OBJECTIVE: To evaluate the safety, efficacy, and durability of multiple sclerosis (MS) disease stabilization after high-dose immunosuppressive therapy (HDIT) and autologous hematopoietic cell transplantation (HCT). METHODS: High-Dose Immunosuppression and Autologous Transplantation for Multiple Scle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nash, Richard A., Hutton, George J., Racke, Michael K., Popat, Uday, Devine, Steven M., Steinmiller, Kaitlyn C., Griffith, Linda M., Muraro, Paolo A., Openshaw, Harry, Sayre, Peter H., Stuve, Olaf, Arnold, Douglas L., Wener, Mark H., Georges, George E., Wundes, Annette, Kraft, George H., Bowen, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868/ https://www.ncbi.nlm.nih.gov/pubmed/28148635 http://dx.doi.org/10.1212/WNL.0000000000003660

Ejemplares similares

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
por: Bowen, James D., et al.
Publicado: (2011)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
por: Saccardi, R, et al.
Publicado: (2012)

RELAPSE AND REMITTING COVID-19 INFECTIONS IN AN IMMUNOSUPPRESSED PATIENT ON CHRONIC RITUXIMAB INFUSIONS
por: GREWAL, SAHIB, et al.
Publicado: (2021)

New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come
por: Nicholas, J., et al.
Publicado: (2012)

The Risk of Immunosuppression: A Case of Salmonella Meningitis
por: Dower, Joshua, et al.
Publicado: (2018)

Decisions in HCT and wine-making
por: McCann, Shaun
Publicado: (2020)

Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020)

COVID-19, HCT and wine
por: McCann, Shaun R.
Publicado: (2020)

The effect of weather on HCT and vines
por: McCann, Shaun R.
Publicado: (2021)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
por: AlSharoqi, Isa Ahmed, et al.
Publicado: (2020)

UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017)

Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein
por: Jenkins, Bryony, et al.
Publicado: (2017)

Self-referential Processing in Remitted Depression: An Event-Related Potential Study
por: Allison, Grace O., et al.
Publicado: (2021)

Inflammation in lung transplantation for CF: Immunosuppression and modulation of inflammation
por: Mallory, George B.
Publicado: (2002)

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
por: Kleist, Christian, et al.
Publicado: (2016)

P1333: PLASMA EXCHANGE, IMMUNOGLOBULIN & PRE-TRANSPLANT IMMUNOSUPPRESSION: AN EFFECTIVE DESENSITISATION STRATEGY FOR DSA ALLOANTIBODIES IN HAPLOIDENTICAL HCT FOR PAEDIATRIC RED CELL DISORDERS
por: Dexter, D., et al.
Publicado: (2022)

What They Say in Remitting
Publicado: (1910)

The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death
por: Huang, Yu-Han, et al.
Publicado: (2015)

Cortical Shape and Curvedness Analysis of Structural Deficits in Remitting and Non-Remitting Depression
por: Liao, Yuan-Lin, et al.
Publicado: (2013)

Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study
por: Neufeld, Nicholas H., et al.
Publicado: (2018)

Treatment of AML Relapse After Allo-HCT
por: Webster, Jonathan A., et al.
Publicado: (2021)

Maintenance therapy for AML after allogeneic HCT
por: Nayak, Rahul K., et al.
Publicado: (2022)

The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023)

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
por: Passweg, Jakob R., et al.
Publicado: (2019)

CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS
por: Limmroth, Volker, et al.
Publicado: (2014)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma
por: Jaglowski, Samantha M., et al.
Publicado: (2014)

Novel Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) Syndrome due to Insulin Therapy
por: Mainali, Naba Raj, et al.
Publicado: (2014)

Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells
por: Uchenunu, Oro, et al.
Publicado: (2022)

Impulsivity in remitted bipolar disorder
por: Lajmi, I., et al.
Publicado: (2021)

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
por: Lillegraven, Siri, et al.
Publicado: (2019)

Structural and dynamic basis of substrate permissiveness in hydroxycinnamoyltransferase (HCT)
por: Chiang, Ying-Chih, et al.
Publicado: (2018)

The contribution of the intestinal microbiome to immune recovery after HCT
por: Wolfe, Alex E., et al.
Publicado: (2022)

T182. SHARED AND DISTINCT ALTERATIONS IN THE WHITE MATTER TRACTS OF REMITTED AND NON-REMITTED PATIENTS WITH SCHIZOPHRENIA
por: Hwang, Tzung-Jeng, et al.
Publicado: (2018)

Enhanced Functional Connectivity Within Executive Function Network in Remitted or Partially Remitted MDD Patients
por: Wang, Yuchen, et al.
Publicado: (2021)

Attentional bias for negative, positive, and threat words in current and remitted depression
por: Elgersma, Hermien J., et al.
Publicado: (2018)

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study
por: Naismith, Robert T, et al.
Publicado: (2019)

Social rhythms and occupational functioning disturbance in remitted bipolar patients
por: Cheikh Ahmed, A. Ben, et al.
Publicado: (2021)

Multiplex, megaplex, index, and complex: the present and future of laboratory diagnostics in rheumatology
por: Wener, Mark H
Publicado: (2011)

Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
por: Monson, Nancy L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0nn9kcfataq1ltamijr2ok14m1